ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$8.42
-1.75%
Mkt Cap $1.97B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (7 analysts)
$22.50
Range $21.00 – $24.00
Implied Upside
+167.4%
Consensus $22.50 vs current $8.42
NASDAQ·Healthcare·Biotechnology
$8.42
-1.75%
Mkt Cap $1.97B
Buy
3
Hold
1
Sell
0
Price Target (7 analysts)
$22.50
Range $21.00 – $24.00
+167.4%
Consensus $22.50 vs current $8.42